Otto Martin Lehmann

Title: Otto Martin Lehmann: Innovator in Biotechnological Production of Vitamin D3

Introduction

Otto Martin Lehmann is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the production of vitamin D3. With a total of 3 patents to his name, Lehmann's work focuses on enhancing the efficiency and specificity of enzymatic processes.

Latest Patents

Lehmann's latest patents include innovations that are pivotal for biotechnological applications. One of his key inventions is related to modified sterol acyltransferases. This invention involves enzymes that exhibit improved activity and specificity towards the acylation of the vitamin D3 precursor, 7-dehydrocholesterol (7-DHC). These modified enzymes are intended for use in the biotechnological production of vitamin D3. Additionally, he has developed an improved method for the production of 7-dehydrocholesterol, which is an important intermediate in the synthesis of vitamin D3 and its derivatives. This method features modified yeast strains that express enzymes with enhanced C-8 sterol isomerase activity, leading to increased ratios of 7-DHC in the sterol mix.

Career Highlights

Lehmann is associated with Dsm IP Assets B.V., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing methods that improve the production processes of vital compounds.

Collaborations

Lehmann has collaborated with notable colleagues, including Christopher Mark Farrell and Lisa Ann Laprade. Their combined expertise contributes to the success of their projects and innovations.

Conclusion

Otto Martin Lehmann's contributions to biotechnology, particularly in the production of vitamin D3, highlight his role as a significant inventor in this field. His innovative patents and collaborations continue to influence advancements in biotechnological processes.